patientx wrote:I don't know, but from my limited understanding it sounds pretty similar to Campath. It looks like the difference might be, whereas Campath, Rituxan, and other MABs, are actually antibodies that bind to T and B cells, this drug causes T cell death by inhibiting NF Kappa B activation (whatever that is). I guess the NF Kappa B is involved in activating inflammatory T-cells, so maybe that's how it leaves "good" T-cells unharmed.
patientx wrote:NHE wrote:Several supplements inhibit NFkB such as EGCG, curcumin, and R-lipoic acid.
Interesting. Do you have some research that you could point to about these things inhibiting NFkB?
Users browsing this forum: No registered users